Dr. Hariprasad G
- Last Updated On :
Dr. Hariprasad G
|
|||||||||
Designation |
Additional Professor |
||||||||
|
This email address is being protected from spambots. You need JavaScript enabled to view it. ; This email address is being protected from spambots. You need JavaScript enabled to view it. |
||||||||
Contact Number |
+91-11-26594240 |
||||||||
Educational Qualifications |
M.D., Ph.D |
||||||||
Research Interests |
Biomarker discovery; Structure Based Drug Design; Medical Education |
||||||||
Awards and Honors
|
|
||||||||
Recent Significant Publications
|
Gupta AK, Pokhriyal R, Khan MI, Kumar DR, Gupta R, Chadda RK, Ramachanran R, Goyal V, Tripathi M, Hariprasad. G*. Cerebrospinal fluid proteomics for identification of α2-macroglobulin as a potential biomarker to monitor pharmacological therapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia. Neuropsychiatric Disease Treatment. (2019) 15: 2853-2867 |
||||||||
Gupta AK, Pokhriyal R, Das U, Khan MI, Kumar DR, Gupta R, Chadda RK, Ramachanran R, Goyal V, Tripathi M, Hariprasad. G*. Evaluation of α-synuclein and apolipoprotein E as potential biomarkers in CSF to monitor pharmaco-therapeutic efficacy in dopamine dictated disease states of Parkinson’s disease and schizophrenia. Neuropsychiatric Disease Treatment. (2019) 15: 2073-2085 |
|||||||||
Gupta AK, Kumar GK, Rani K, Pokhriyal R, Khan MI, Kumar DR, Goyal V, Tripathi M, Gupta R, Chadda RK, Vanamail P, Mohanty AK, Hariprasad. G*. 2D-DIGE as a strategy to identify serum protein biomarkers to monitor pharmacological efficacy in dopamine dictated states of Parkinson’s disease and schizophrenia. Neuropsychiatric Disease Treatment. (2019) 15: 1031-1044. |
|||||||||
Gupta AK, Rani K, Swarnkar S, Kumar GK, Khan MI, Pokhriyal R, Kumar DR, Goyal V, Tripathi M, Gupta R, Chadda RK, Vanamail P, Hariprasad G*. Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia and Parkinson's disease: A Preliminary Study. J Cent Nerv Syst Dis. (2018) 10:1179573518803585. eCollection |
|||||||||
Sehrawat U, Pokhriyal R, Gupta AK, Hariprasad R, Khan I, Gupta D, Naru J, Singh SB, Mohanty AK, Vanamail P, Kumar L, Kumar S, Hariprasad G*. Comparative proteomic analysis of advanced ovarian cancer tissue to identify potential biomarkers of responders and non-responders to first line chemotherapy of carboplatin and paclitaxel. Biomarkers in Cancer (2016) 8:43-56 |
|||||||||
Khan MI, GuptaAK, KumaR, Ethayathulla AS, Kumar M, Hariprasad G*. Molecular modeling of Gly80 and Ser80 variants of human group IID phospholipase A2 and their receptor complexes: potential basis for weight loss in chronic obstructive pulmonary disease. Journal of Molecular Modeling (2016) 22:232 |
|||||||||
Hariprasad G, Hariprasad R, Kumar L, Srinivasan A, Srujana K, Kaushik A. Apolipoprotein A1 as a potential biomarker in the ascetic fluid for the differentiation of advanced ovarian cancers. (2013) Biomarkers. 18: 532-41. |
|||||||||
Hariprasad G, Kota D, Singh SB, Srinivasan A, Adhikary S. Delineation of the structural elements of oriental liver fluke PLA2 isoforms for potent drug designing.(2014) Indian J Clin Biochem. In Press |
|||||||||
Hariprasad G, Srinivasan A, Singh R. Structural and phylogenetic basis for the classification of group III phospholipase A2. (2013) J Mol Model. 19: 3779-91 |
|||||||||
Hariprasad G*, Kaur P, Srinivasan A, Singh TP, Kumar M. Structural analysis of secretory phospholipase A2 from Clonorchis sinensis: therapeutic implications for hepatic fibrosis. (2012) J Mol. Model. 18: 3139-3145. |
|||||||||
Hariprasad G*, Kaur P, Srinivasan A, Singh TP, Kumar M. Structural analysis of secretory phospholipase A2 from Clonorchis sinensis: therapeutic implications for hepatic fibrosis. (2012) J Mol. Model. 18: 3139-3145 |
|||||||||
Hariprasad G, Kumar M, Rani K, Kaur P, Srinivasan A. (2012) Aminoglycoside induced nephrotoxicity: Molecular modeling studies of the calreticulin-gentamicin complex. J Mol. Model. 18: 2645-2652. |
|||||||||
Hariprasad G, Kumar M, Srinivasan A, Kaur P, Singh TP, Jithesh O. (2011) Structural analysis of a group III Glu62-phospholipase A2 from the scorpion, Mesobuthus tamulus: targeting and reversible inhibition by native peptides. Int. J Biol. Macromol. 48: 423–431. |
|||||||||
Hariprasad G, Srinivasan A, Vedakumari Y. (2011) Electrical conductivity as a tool to detect salt in clinical proteomics samples. Indian J Clin. Biochem. 26: 82-83. |
|||||||||
Hariprasad G, Kumar M, Kaur P, Singh TP, Kumar RP. (2010) Human group III PLA2 as a drug target: Structural analysis and inhibitor binding studies. Int. J Biol. Macromol. 47: 496-501 |
|||||||||
Hariprasad G(2008) Rationale for student exposure to pre- and para medical sciences as part of internship. Med. Educ. 42: 645. |
|||||||||
Hariprasad G (2008) Holistic presentation of the under graduate medical curriculum. Med. Educ. 42: 849. Omicron Spike protein trimer model Omicron Spike protein (RBD)_Human ACE-2 receptor complex model at 100ns MD
|